P. Bounameaux, Utilisation des héparines de bas poids moléculaire dans quatre situations cliniques controversées (immobilisation plâtrée, arthroscopie du genou, grossesse, et voyages) Prises de position d'un groupe d'experts suisses Société Suisse d'Angiologie, Société Suisse de Phlébologie Bulletin des médecins suisses / Bollettino dei medici svizzeri, Nr, vol.82, issue.17, p.866, 2001.

A. Turpie, Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in medical patients with enoxaparin (MEDENOX) trial, The American Journal of Cardiology, vol.86, issue.12, pp.48-52, 2000.
DOI : 10.1016/S0002-9149(00)01481-8

T. Paul, . Vaitkus, . Leizorovicz, and . Goldhaber, Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: the prospective evaluation of dalteparin efficacy for prevention of venous thromboembolism in immobilized patients trial (the PREVENT study), Vascular Medicine, vol.7, issue.4, pp.269-273, 2002.

P. Mismetti, Pr??vention de la maladie thromboembolique en orthop??die et traumatologie, Annales Fran??aises d'Anesth??sie et de R??animation, vol.24, issue.8, pp.871-889, 2005.
DOI : 10.1016/j.annfar.2005.06.007

E. Ferrari, . Chevalliert, . Chapeliera, and M. Baudouy, Travel as a Risk Factor for Venous Thromboembolic Disease, Chest, vol.115, issue.2, pp.440-444, 1999.
DOI : 10.1378/chest.115.2.440

S. Cannegieter, C. Doggen, H. Van-houwelingen, and F. Rosendaal, Travel-Related Venous Thrombosis: Results from a Large Population-Based Case Control Study (MEGA Study), PLoS Medicine, vol.367, issue.8, p.307, 2006.
DOI : 10.1371/journal.pmed.0030307.sd002

H. Decousus, P. Prandoni, and P. Mismetti, Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs, New England Journal of Medicine, vol.363, issue.13, pp.1222-1254, 2010.
DOI : 10.1056/NEJMoa0912072

URL : https://hal.archives-ouvertes.fr/hal-00927770

G. Motykie, L. Zebala, J. Caprini, C. Lee, J. Arcelus et al., A guide to venous Thromboembolism risk factor assessment, Journal of Thrombosis and Thrombolysis, vol.9, issue.3, pp.253-262, 2000.
DOI : 10.1023/A:1018770712660

J. Edelsberg, D. Ollendorf, and G. Oster, Venous thromboembolism following major orthopedic surgery: review of epidemiology and economics, AmJ Health Syst Pharm, vol.58, issue.2, pp.4-13, 2001.

F. Rosendaal, Risk factors for venous thrombotic disease, Thromb Haemost, vol.82, pp.610-619, 1999.

I. Martinelli, Risk factors in venous thromboembolism, Thromb Haemost, vol.86, pp.395-403, 2001.

G. Gensini, D. Prisco, M. Falciani, M. Comeglio, and A. Colella, Identification of Candidates for Prevention of Venous Thromboembolism, Seminars in Thrombosis and Hemostasis, vol.23, issue.01, pp.55-56, 1997.
DOI : 10.1055/s-2007-996071

V. Eschwege and A. Robert, Strikes in French public transport and resistance to activated protein C, The Lancet, vol.347, issue.8995, p.206, 1996.
DOI : 10.1016/S0140-6736(96)90393-1

I. Martinelli, Risk factors in venous thromboembolism, Thromb Haemost, vol.86, pp.395-403, 2001.

P. Mismetti, Pr??vention de la maladie thromboembolique en orthop??die et traumatologie, Annales Fran??aises d'Anesth??sie et de R??animation, vol.24, issue.8, pp.871-889, 2005.
DOI : 10.1016/j.annfar.2005.06.007

A. Turpie, Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in medical patients with enoxaparin (MEDENOX) trial, The American Journal of Cardiology, vol.86, issue.12, pp.48-52, 2000.
DOI : 10.1016/S0002-9149(00)01481-8

T. Paul, . Vaitkus, . Leizorovicz, and . Goldhaber, Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: the prospective evaluation of dalteparin efficacy for prevention of venous thromboembolism in immobilized patients trial (the PREVENT study), Vascular Medicine, vol.7, issue.4, pp.269-273, 2002.

T. Alexander and . Cohen, Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial, BMJ, vol.332, issue.7537 11, pp.325-354, 2006.

J. Bosson, J. Pouchain, and . Bergmann, A prospective observational study of a cohort of outpatients with an acute medical event and reduced mobility: incidence of symptomatic thromboembolism and description of thromboprophylaxis practices, Journal of Internal Medicine, vol.91, issue.24, pp.168-176, 2006.
DOI : 10.1007/s11239-004-0208-6

URL : https://hal.archives-ouvertes.fr/hal-00281342

P. Kujath, U. Spannagel, and W. Habscheid, Incidence and Prophylaxis of Deep Venous Thrombosis in Outpatients with Injury of the Lower Limb, Pathophysiology of Haemostasis and Thrombosis, vol.23, issue.1, pp.20-26, 1993.
DOI : 10.1159/000216905

H. Kock, K. Schmit-neuerburg, J. Hanke, G. Rudofsky, and H. Hirche, Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg, The Lancet, vol.346, issue.8973, pp.459-61, 1995.
DOI : 10.1016/S0140-6736(95)91320-3

P. Jorgensen, T. Warming, K. Hansen, and C. Palved, Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast, Thrombosis Research, vol.105, issue.6, pp.477-80, 2002.
DOI : 10.1016/S0049-3848(02)00059-2

M. Lassen, L. Borris, and R. Nakov, Use of the Low-Molecular-Weight Heparin Reviparin to Prevent Deep-Vein Thrombosis after Leg Injury Requiring Immobilization, New England Journal of Medicine, vol.347, issue.10, pp.726-756, 2002.
DOI : 10.1056/NEJMoa011327